Patents by Inventor Elena DICHIARANTE

Elena DICHIARANTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE POLYMORPHS OF 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL
    Publication number: 20220213014
    Abstract: Described herein are polymorphic forms of 1,6-dibromo-1,6-dideoxy-dulcitol (dibromo dulcitol or DBD), which is a known antitumor agent.
    Type: Application
    Filed: March 24, 2022
    Publication date: July 7, 2022
    Applicant: Eleison Pharmaceuticals LLC
    Inventors: Stefano Luca Giaffreda, Elena Dichiarante
  • Crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol
    Patent number: 11312675
    Abstract: Described herein are polymorphic forms of 1,6-dibromo-1,6-dideoxy-dulcitol (dibromo dulcitol or DBD), which is a known antitumor agent. Also described are methods of making these new crystalline polymorphic forms as well as methods of using these polymorphic forms to treat cancer.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: April 26, 2022
    Assignee: Eleison Pharmaceuticals, LLC
    Inventors: Stefano Luca Giaffreda, Elena Dichiarante
  • NEW CRYSTALLINE POLYMORPHS OF 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL
    Publication number: 20200270193
    Abstract: Described herein are polymorphic forms of 1,6-dibromo-1,6-dideoxy-dulcitol (dibromo dulcitol or DBD), which is a known antitumor agent. Also described are methods of making these new crystalline polymorphic forms as well as methods of using these polymorphic forms to treat cancer.
    Type: Application
    Filed: May 12, 2020
    Publication date: August 27, 2020
    Applicant: Targent, LLC
    Inventors: Stefano Luca Giaffreda, Elena Dichiarante
  • Crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol
    Patent number: 10654783
    Abstract: Described herein are polymorphic forms of 1,6-dibromo-1,6-dideoxy-dulcitol (dibromo dulcitol or DBD), which is a known antitumor agent. Also described are methods of making these new crystalline polymorphic forms as well as methods of using these polymorphic forms to treat cancer.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: May 19, 2020
    Assignee: Targent, LLC
    Inventors: Stefano Luca Giaffreda, Elena Dichiarante
  • NEW CRYSTALLINE POLYMORPHS OF 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL
    Publication number: 20180362427
    Abstract: Described herein are polymorphic forms of 1,6-dibromo-1,6-dideoxy-dulcitol (dibromo dulcitol or DBD), which is a known antitumor agent. Also described are methods of making these new crystalline polymorphic forms as well as methods of using these polymorphic forms to treat cancer.
    Type: Application
    Filed: June 15, 2016
    Publication date: December 20, 2018
    Applicant: Targent, LLC
    Inventors: Stefano Luca Giaffreda, Elena Dichiarante
  • Crystalline forms of an antidepressant compound
    Patent number: 9687484
    Abstract: The present invention relates to novel crystalline forms of vortioxetine hydrobromide, in particular three crystalline forms, a process for their preparation, a pharmaceutical composition containing said novel crystalline forms, and a process for the purification of vortioxetine or a salt thereof, comprising the formation of one or more of the novel crystalline forms of vortioxetine hydrobromide described herein.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: June 27, 2017
    Assignee: Dipharma Francis S.r.l.
    Inventors: Stefano Luca Giaffreda, Marco Curzi, Elena Dichiarante, Pietro Allegrini, Renzo Graziosi, Chiara Vladiskovic
  • CRYSTALLINE FORMS OF AN ANTIDEPRESSANT COMPOUND
    Publication number: 20160015706
    Abstract: The present invention relates to novel crystalline forms of vortioxetine hydrobromide, in particular three crystalline forms, a process for their preparation, a pharmaceutical composition containing said novel crystalline forms, and a process for the purification of vortioxetine or a salt thereof, comprising the formation of one or more of the novel crystalline forms of vortioxetine hydrobromide described herein.
    Type: Application
    Filed: July 6, 2015
    Publication date: January 21, 2016
    Applicant: DIPHARMA FRANCIS S.r.l.
    Inventors: Stefano Luca GIAFFREDA, Marco CURZI, Elena DICHIARANTE, Pietro ALLEGRINI, Renzo GRAZIOSI, Chiara VLADISKOVIC